−35.71USD
−16.08 MUSD
751.91 K
About Bio-Path Holdings, Inc.
Sector
Industry
CEO
Peter H. Nielsen
Website
Headquarters
Bellaire
Employees (FY)
10
Founded
2007
ISIN
US09057N4097
FIGI
BBG000PQXTT3
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BPTH is 6.23 USD — it has increased by 92.28% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bio-Path Holdings, Inc. stocks are traded under the ticker BPTH.
Bio-Path Holdings, Inc. is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
BPTH stock is 91.15% volatile and has beta coefficient of 0.65. Check out the list of the most volatile stocks — is Bio-Path Holdings, Inc. there?
One year price forecast for Bio-Path Holdings, Inc. has a max estimate of 40.00 USD and a min estimate of 40.00 USD.
BPTH earnings for the last quarter are −6.40 USD whereas the estimation was −6.80 USD which accounts for 5.88% surprise. Estimated earnings for the next quarter are −5.40 USD. See more details about Bio-Path Holdings, Inc. earnings.
Yes, you can track Bio-Path Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
BPTH stock has risen by 79.54% compared to the previous week, the month change is a 30.88% rise, over the last year Bio-Path Holdings, Inc. has showed a 80.03% decrease.
BPTH net income for the last quarter is −3.37 M USD, while the quarter before that showed −3.20 M USD of net income which accounts for −5.41% change. Track more Bio-Path Holdings, Inc. financial stats to get the full picture.
Today Bio-Path Holdings, Inc. has the market capitalization of 2.44 M, it has decreased by 8.15% over the last week.
No, BPTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BPTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bio-Path Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 10.00 employees. See our rating of the largest employees — is Bio-Path Holdings, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bio-Path Holdings, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bio-Path Holdings, Inc. stock shows the sell signal. See more of Bio-Path Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Bio-Path Holdings, Inc. future price: according to them, BPTH price has a max estimate of 40.00 USD and a min estimate of 40.00 USD. Read a more detailed Bio-Path Holdings, Inc. forecast: see what analysts think of Bio-Path Holdings, Inc. and suggest that you do with its stocks.